Top Rated

ANDA Litigation and Reverse Payments

In Federal Trade Commission v. Watson Pharmaceuticals, Inc., No. 133 S. Ct. 787 (2012), the Supreme Court held that reverse payments in pharmaceuticals patent settlement are not categorically immune from the antitrust laws even if such payments fall within the scope of the patent. Often, reverse payments are made by a pioneer drug manufacturer to a generic drug manufacturer in settlement of a patent challenge. In exchange for the payment, the generic




Federal Circuit and Advisory Council Model Orders

On July 22, 2013, a model order relating to the number of asserted claims and prior art references in patent litigations was released on the Federal Circuit Advisory Council’s webpage. The order required that in the first phase, plaintiffs must select 10 claims per patent, and 32 claims total, 40 days after production of “core” technical documents, while defendants are limited to 12 prior art references per patent and 40




Patent Attorney

In WiAV Solutions LLC v. Motorola, Inc., No. 10-1266 (Fed. Cir. Dec. 22, 2010), the Federal Circuit broadened the scope of exclusive license by holding that “a licensee is an exclusive licensee of a patent if it holds any of the exclusionary rights that accompany a patent.” The licensing rights at issue were held by six third-parties and seven patents owned by Mindspeed Technologies, Inc. After a series of spin-offs




Do Business Method Patents Hurt or Help?

Do Business Method Patents Hurt or Help? A Financial Industry Perspective, 14 VA. J.L. & TECH. 147 (2009). Abstract The State Street Bank decision of 1998 affirmed U.S. business method patents. Along with the subsequent downpour of patent filings came a shower of commentary from the legal and business communities alike. The literature has generally been thoughtful and well-reasoned, or at least well-meaning. But as practitioners in the fields, we




Clients

Our legal services are offered to the leading corporations, governmental and quasi-governmental organizations, startup companies, research associations and technology creators the world over. With nearly two decades of experience per average lawyer, our counselors have represented leaders in their industries.




Post Grant Proceedings

Aside from litigation before the federal district courts, the validity of granted U.S. patents may be challenged before the U.S. Patent and Trademark Office. Post grant proceedings are in fact a changing and vibrant area of patent law, as the America Invents Act (AIA)  has changed the landscape for such post grant challenges. Following AIA, the collection of post grant proceedings used to effect patent validity challenges comprises Ex Parte




Strategic IP Counseling

IPLL evaluates the business strength of technologies through market segmentation and detailed analyses of relevant systems, products and employed methodologies. We employ the services of leading experts in the relevant technologies as well as experts in damages. In the high technology area, representative industries include electronics, telecommunications, Internet, software, computer hardware, financial services, semiconductors and optical systems. In the sciences industries, representative industries include biotechnology, medical devices and pharmaceuticals. Our




The Lanham Act and Jim Brown

On July 31, 2013, the Ninth Circuit affirmed dismissal of the Lanham Act claims brought by Jim Brown, a former NFL star, against video game developer Electronic Arts, Inc. (EA). The court concluded that the Rogers balancing test was the appropriate standard to evaluate defendant EA’s use of Brown’s likeness in video games, and since the use of his likeness was artistically relevant to games, it is protected by the




Assignment of Intent-to-use Trademark Applications

The Trademark Act Section 10(a)(1) clearly states that an intent-to-use application cannot be assigned “except for an assignment to a successor to the business of the applicant, or portion thereof, to which the mark pertains, if that business is ongoing and existing.” In the recent Trademark Trial and Appeal Board case, Cent. Garden & Pet Co. v. Doskocil Mfg. Co., No. 91188816 (TTAB August 16, 2013), All-Glass Aquarium Co., a




Trade Secrets Litigation

At no other time in history have trade secrets been so vital to the making or breaking of a company. Modern firms, from startups to multinationals, face new challenges daily, as the speed of information exchange itself accelerates to keep up with technology shifts, changing trends and competitive challenge. Yet, as swiftly as companies must exchange information to stay in the game, so may competitive advantages built on years of